Holly Alberti

🧪 Lab Integrity Isn’t Optional — It’s Foundational to a Safe Cannabis Market 🧪 Recent developments in the Massachusetts cannabis industry have brought long-overdue attention to a critical issue: the integrity of lab testing. In June, the Massachusetts Cannabis Control Commission (CCC) rolled out several key reforms aimed at improving transparency, accuracy, and consumer safety. These updates include: ✅ Mandatory uploads of Certificates of Analysis (COAs) to METRC, with clear descriptions of testing methods ✅ A requirement that samples be sent to a single Independent Testing Lab (ITL) to reduce cherry-picking ✅ The introduction of “reference labs” to independently verify analytical accuracy across the state Why is this important? Because inconsistent or inflated lab results don’t just distort the market—they put public health at risk and undermine trust in the legal cannabis supply chain. At Smithers - Cannabis Testing Services, we believe trust begins with transparent science. Our mission is to provide data that’s reliable, defensible, and accurate…because our partners deserve nothing less. Whether it’s potency, contaminants, or shelf stability, we stand by results that protect consumers and elevate brands built to last. If your business is built to last, your testing should be too. When evaluating a lab, ask: 🔬 Are their testing methods clearly documented and transparent? 📊 Do their results remain consistent over time and across product types? 🧾 Do they welcome questions and provide detailed, reliable COAs? 🚫 Do they resist pressure to inflate THC levels or “pass” questionable samples? The CCC’s recent steps are a big move in the right direction, but they’re only part of the solution. It’s up to cultivators, processors, retailers, and consumers to demand better and support labs that play it straight. Let’s build this industry the right way…grounded in science, integrity, and trust. If you’re ready for a lab partner who puts data and ethics first, let’s talk.

20

Most people think cannabis product development is about the plant. It’s not. It’s about project management. Because behind every compliant package on a dispensary shelf is a quiet orchestra of timelines, regulations, vendors, formulations, testing labs, packaging delays, state rules that change mid-sentence, and teams trying to hit a launch date that actually matters to revenue. That’s where real project management steps in. Not the fluffy, color-coded-for-fun kind. The kind that: • Aligns cultivation, manufacturing, compliance, branding, and sales into one executable path • Anticipates regulatory friction before it becomes a six-figure mistake • Protects margin, speed to market, and team sanity at the same time • Turns “almost ready” into on-shelf and selling In cannabis, product development without disciplined project management isn’t innovation. It’s gambling. And in a regulated, margin-tight industry… gambling is expensive. The companies that win over the next five years won’t just have great genetics or beautiful branding. They’ll have operators who can move complex ideas through real-world constraints and land them in market cleanly, compliantly, and profitably. That’s project management. Quiet power. Real revenue. No drama. If you’re building in cannabis right now, this isn’t optional anymore. It’s infrastructure. #projectcannabis #cannabis #projectmanagement Travis Cox Jessica Cox Loving The Plant 🌱

32

14 Comments

The hemp industry is at a crossroads. And it’s not about bubbles vs gummies. It’s about whether policy will protect an entire regulated category… or carve it down to what fits neatly inside a cooler. I just published a new opinion piece titled: “When Alcohol Giants Pick Profits Over Patients.” In it, I explore: • Why “safety” arguments often focus on format instead of dose • What the Minnesota model proves about compliant edibles • How beverage-only carve-outs could reshape the hemp market • Why consumers who rely on low-dose THC for sleep and pain should be paying attention This isn’t an accusation piece. It’s a market structure discussion. For many consumers, this isn’t about novelty. It’s about access. If you believe hemp regulation should focus on testing, labeling, and responsible dose limits — not just packaging format — this conversation matters. I’d genuinely like to hear from: • Retailers • Regulators • Distributors • Consumers • Fellow operators Should hemp policy be comprehensive? Or should it prioritize one format over the rest? Read the full article here: https://lnkd.in/g46fGuKj Let’s have the conversation openly. #HempIndustry #CannabisPolicy #THC #Regulation #Retail #MinnesotaModel #ConsumerAccess

20

4 Comments